Unavailable
Unavailable
Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)
4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)
5 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)
11-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)
8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)
8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)
Veteran Dealmaker Brings More Than 25 Years of Healthcare Industry Experience NEW YORK, July 14, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank and wealth manager and a subsidiary of Oppenheimer Holdings (NYSE:OPY), announced today the appointment of Jon Hudson as Managing Director and Co-Head of its Healthcare Services Investment Banking team. Hudson will report to Michael Margolis, R.Ph., Head of Oppenheimer's Healthcare Investment Banking Group, and work out of the firm's Miami and Atlanta offices. "On behalf of the entire Healthcare Investment Banking group, I'm pleased to welcome Jon to Oppenheimer," said Margolis. "Jon is a highly respected advi
NEW YORK, April 25, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $30.7 million or $2.93 basic earnings per share for the first quarter of 2025, compared with net income of $26.1 million or $2.50 basic earnings per share for the first quarter of 2024. Revenue for the first quarter of 2025 was $367.8 million, an increase of 4.2%, compared to revenue of $353.1 million for the first quarter of 2024. Albert G. Lowenthal, Chairman and CEO commented, "The Firm's solid performance for the quarter underscores the ability of our diversified businesses to deliver profitable operating results in increasingly uncertain macroeconomic cond
NEW YORK, March 25, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. — a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE:OPY) — announced today that Ranjot Singh has joined the Firm as a Managing Director in its Technology Investment Banking Group. He will be based in Oppenheimer's New York office and report to Robin Graham, Head of Technology Investment Banking. "Ranjot's M&A expertise with large and highly technical transactions across the Technology sector is the perfect addition to our growing advisory practice," Graham said. "He has advised both public and private companies at the highest levels and will complement the deep industry expertise of our most
NEW YORK, April 25, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $30.7 million or $2.93 basic earnings per share for the first quarter of 2025, compared with net income of $26.1 million or $2.50 basic earnings per share for the first quarter of 2024. Revenue for the first quarter of 2025 was $367.8 million, an increase of 4.2%, compared to revenue of $353.1 million for the first quarter of 2024. Albert G. Lowenthal, Chairman and CEO commented, "The Firm's solid performance for the quarter underscores the ability of our diversified businesses to deliver profitable operating results in increasingly uncertain macroeconomic cond
NEW YORK, Jan. 31, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of 2024 compared with net income of $11.1 million or $1.07 basic earnings per share for the fourth quarter of 2023. Fourth quarter and full year 2024 results were significantly impacted by higher pre-tax compensation expenses for liability-based awards totaling $20.5 million and $32.6 million, respectively, attributable to an increase in OPY Class A share price. Revenue for the fourth quarter of 2024 was $375.4 million compared to revenue of $308.3 million for the fourth quarter of 2023, an in
NEW YORK, Oct. 25, 2024 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $24.5 million or $2.38 basic earnings per share for the third quarter of 2024, compared with net income of $13.9 million or $1.32 basic earnings per share for the third quarter of 2023. Revenue for the third quarter of 2024 was $373.4 million, an increase of 19.4%, compared to revenue of $312.7 million for the third quarter of 2023. Albert G. Lowenthal, Chairman and CEO commented, "The Firm delivered strong operating results for the quarter in a still-resilient economic environment. During the third quarter, all major indices reached new highs, mostly spurred b
SC 13G/A - OPPENHEIMER HOLDINGS INC (0000791963) (Subject)
SC 13G - OPPENHEIMER HOLDINGS INC (0000791963) (Subject)
Veteran Dealmaker Brings More Than 25 Years of Healthcare Industry Experience NEW YORK, July 14, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank and wealth manager and a subsidiary of Oppenheimer Holdings (NYSE:OPY), announced today the appointment of Jon Hudson as Managing Director and Co-Head of its Healthcare Services Investment Banking team. Hudson will report to Michael Margolis, R.Ph., Head of Oppenheimer's Healthcare Investment Banking Group, and work out of the firm's Miami and Atlanta offices. "On behalf of the entire Healthcare Investment Banking group, I'm pleased to welcome Jon to Oppenheimer," said Margolis. "Jon is a highly respected advi
NEW YORK, March 25, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. — a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE:OPY) — announced today that Ranjot Singh has joined the Firm as a Managing Director in its Technology Investment Banking Group. He will be based in Oppenheimer's New York office and report to Robin Graham, Head of Technology Investment Banking. "Ranjot's M&A expertise with large and highly technical transactions across the Technology sector is the perfect addition to our growing advisory practice," Graham said. "He has advised both public and private companies at the highest levels and will complement the deep industry expertise of our most
LONDON, March 12, 2025 /PRNewswire/ -- Oppenheimer Europe (Oppenheimer) — a subsidiary of Oppenheimer Holdings, the leading investment bank and wealth manager (NYSE:OPY) — announced today a significant expansion to its European investment banking team with the addition of three highly experienced senior investment bankers in London. They join the firm from boutique Hannam & Partners and will report to Max Lami, CEO of Oppenheimer European business. The team includes Ernest Bell, Managing Director, European Head of Public M&A and Wealth Management; Giles Fitzpatrick, Vice Chairman and Managing Director of European Investment Banking; and Richard Clarke, Senior Advisor. They will be joined by